View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Nivolumab 3 / Ipilimumab 1 / Cabozantinib 40 - Nivolumab 480 / Cabozantinib 40 Maintenance, Renal Cell Carcinoma, Cycle 5+
Protocol-ID: 2353 V1.0 (Mini), NIVO3/IPIL1/CABO40 - NIVO480/CABO40 maint., RCC, C5+Indication(s)
- Renal Cell Carcinoma; ICD-10 C64
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 31.05.2023